Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: To all: I've noticed that some posters are asking

"We buy back 45M shares for 10M approx. , 391M - 45M taken out of circulation= 341M shares still outstanding. Still to many to make that much of a difference."

OK, this is where we are not on the same page. I am not recommending that we buy back stock to reduce OS. Rather, I am advocating that management invest in PTSC, buy back stock at a discounted rate, put the repurchased stock in the Treasury for a rainy day when it is worth more, i.e. after we kick the $hit out of the J's in Texas, and than use the much hire valued stock for M/A. Make sense? All my opinion of course. Good luck to you, me, us, and all longs.

Share
New Message
Please login to post a reply